The interpretation of serology and hormone testing results for Assisted Reproductive Technology (ART) requires a level of expertise specific to infertility.

Following discussion with the Fertility Society of Australia (FSA), Scientists in Reproductive Technologies (SIRT) and Medical Testing Accreditation Advisory Committee members, laboratories are advised that the subclasses of tests available under a scope of accreditation for assisted reproductive procedures has been updated to acknowledge this level of expertise.

Such testing carried out by fertility laboratories will now be represented in the scope of accreditation as follows:

10.95	Assisted reproduction procedures
	.14	Hormones
	.15	Serology testing Descriptor identifying particular test/s eg HCV, HIV.

Consideration was also given to the addition of genetic testing, however, as this area of testing is currently performed by a limited number of laboratories, it will not be included under 10.95 at this stage and will remain under 10.70 Genetic Testing.

Other specialised assays such as cancer antigens will be listed under 10.95.99 Miscellaneous.

If you have any further questions, please do not hesitate to contact Andrew Griffin, Deputy Field Manager, Medical Testing or Panagiota Caragianni, Scientific Officer, Medical Testing on (02) 9736 8222.